Bli medlem
Bli medlem

Du är här


BrainCool: BrainCool AB (publ) - new order for BrainCoolT System in Germany

BrainCool has received yet another order in Germany, this time from
Krankenhaus Martha-Maria in Halle, for the product BrainCool? System.
The order of one system is for cooling treatment of cardiac arrest
patients. Delivery is expected at the beginning of April.

CEO Martin Waleij comments:

This order is a confirmation that the market for medical technology in
intensive care is prioritized even during the turbulence with
Covid-19. Furthermore, the product is implemented in the treatment
chain as a result of patients being initially treated with
RhinoChill?, and then being transferred to the BrainCool? System for
treatment at the ICU.

This information is information that BrainCool (publ) is obliged to
make public pursuant to the EU Market Abuse Regulation. The
information was submitted for publication, through the agency of the
contact person set out herein, on March 31, 2020.

For more information

Martin Waleij - CEO
+46 - 733 -93 70 76

About BrainCool AB (publ)

BrainCool AB (publ) is an innovative medical device company that
develops, markets, and sells leading medical cooling systems for
indications and areas with significant medical benefits within the
healthcare sector. The company focuses on two business segments,
Brain Cooling and Pain Management. BrainCool AB (publ) is based in
Lund, Sweden, and its share is listed on Spotlight Stock Market.


Författare AktieTorget News

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.